Legal Representation
Attorney
Jacqueline M. Lesser
USPTO Deadlines
Application History
18 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 6, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Apr 25, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 10, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 13, 2024 | ETOP | T | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | Loading... |
| Oct 4, 2024 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
| Sep 3, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 3, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 14, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 1, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 26, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 26, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 26, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 28, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 28, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 28, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 24, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 28, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 5, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 009
Downloadable computer software applications for estimating the relative binding free energy to prioritize molecules with efficient physics-based methods; downloadable and recorded computer software platforms using artificial intelligence for automated machine learning in the field of drug design and development; recorded computer software platform for operating programs; data processing apparatus being data processors
Class 042
Technological research in the field of drug design and development and patent mapping; scientific research and development; scientific research and development relating to patent mapping; scientific research in the field of artificial intelligence for drug research and development; research and development of new products; research and development of new products for others; scientific laboratory services, namely laboratory services in drug design and development; cancer research for medical purposes; artificial intelligence consultancy in drug design and development, namely, chemistry services, clinical trials, biomedical research services, medical laboratory services, medical research services; drug research and development; design and development of computer software; custom design of computer software in the field of drug design and development; design and development of computer software for estimating the relative binding free energy to prioritize molecules with efficient physics-based methods; computer software installation, maintenance and repair; installation of computer software using artificial intelligence for automated machine learning in the field of drug design and development; development of computer platforms; research in computer natural language processing; design of computer-simulated models; software as a service (SAAS) services featuring software for using artificial intelligence for automated machine learning in the field of drug design and development; software development in the framework of software publishing; platform as a service (PAAS) featuring computer software platforms for using artificial intelligence for automated machine learning in the field of drug design and development; design and development of computer platforms; computer system design; computer programming services, namely natural language processing; computer programming services, namely creating and designing website-based indexes of information in the field of drug design and development for others using information technology
Classification
International Classes
009
042